| Biochemic and serological profil | n (%) |
| Acute hepatitis B | 1 (0.28) |
| Immune-tolerant phase | 2 (0.56) |
| HBeAg-positive immune-active phase | 5 (1.38) |
| HBeAg-negative immune-active phase | 2 (0.56) |
| Inactive phase | 352 (97.24) |
| Total | 362 |